Q&A: Mixing Science and Politics

Politicians could make better decisions if they thought more like scientists, says Rush Holt, the only physicist in Congress.

Written byBeth Marie Mole
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Rep. Rush Holt, USDAIn the heat of election season, scientists—and 85 percent of voters—are clamoring for candidates to explain their positions on alternative energy sources, climate change policy, and federal funding for research, among other science-related issues. But one scientist-turned-congressman wants more. Representative Rush Holt (D, NJ) doesn’t want politicians to merely think about science, he wants them to think like scientists. In a recent opinion piece in Nature, Holt argued that scientific thinking—based on logic and evidence—could improve lawmakers’ decisions on issues ranging from voting systems to air transportation security. The Scientist spoke with Holt about his thoughts on blending science into politics.

The Scientist: What inspired your opinion that scientific thinking can improve politics?

Rep. Rush Holt: It became apparent to me that my constituents like the fact that I’m a research scientist that decided to go into Congress. And I’ve been asking myself, “Why?” Sometimes people say, “Well, we want somebody who will understand scientific technicalities and languages.” But most of the time I find it’s not that, but rather, people want someone who makes decisions based on evidence. People are really troubled by the idea that politics is driven by ideologies now, and debate is usually just posturing. Science moves away from political spin because it’s tied to evidence. In science, questions are answered provisionally, with the understanding that provisional answers are subject to revision ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies